Abstract
Carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide ([11C]PK11195) is a peripheral benzodiazepine receptor (PBR) antagonist that is used as a positron emission tomography (PET) radiopharmaceutical for neuroinflammatory imaging. This study was designed to investigate the radiation dosimetry of [11C]PK11195.
| Original language | English |
|---|---|
| Journal | Molecular Imaging and Biology |
| Volume | 12 |
| Issue number | 4 |
| Pages (from-to) | 435-42 |
| Number of pages | 8 |
| ISSN | 1536-1632 |
| DOIs | |
| Publication status | Published - 1 Aug 2010 |
Fingerprint
Dive into the research topics of 'Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS